Diplomat Pharmacy (DPLO) Misses Q2 EPS by 6c; Lowers EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Diplomat Pharmacy (DPLO) PT Lowered to $24 at Barclays
August 7, 2018 3:56 AM EDTBarclays lowered its price target on Diplomat Pharmacy (NYSE: DPLO) to $24.00 (from $27.00) while maintaining a Overweight rating.
... More